Are you Dr. Lemon?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 43 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
8.034 Burnett-Womack Cb 7292 Of No
# Univ
Chapel Hill, NC 27599Phone+1 919-843-1848Fax+1 919-843-7240
Summary
- Dr. Stanley Lemon, MD is an infectious disease specialist in Chapel Hill, North Carolina. He is currently licensed to practice medicine in North Carolina, Texas, and Maine. He is a Professor at University of North Carolina at Chapel Hill School of Medicine.
Education & Training
- University of North Carolina HospitalsFellowship, Infectious Disease, 1975 - 1977
- University of North Carolina HospitalsResidency, Internal Medicine, 1972 - 1975
- University of Rochester School of Medicine and DentistryClass of 1972
Certifications & Licensure
- NC State Medical License 1973 - 2025
- TX State Medical License 2002 - 2012
- ME State Medical License Active through 1984
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1987
Clinical Trials
Publications & Presentations
PubMed
- 3 citations"PROTAC" modified dihydroquinolizinones (DHQs) that cause degradation of PAPD-5 and inhibition of hepatitis A virus and hepatitis B virus, in vitro.You Li, Nicky Hwang, Andrew Snedeker, Stanley M Lemon, Daisy Noe
Bioorganic & Medicinal Chemistry Letters. 2024-04-01 - 20 citationsCell entry and release of quasi-enveloped human hepatitis viruses.Anshuman Das, Efraín E Rivera-Serrano, Xin Yin, Christopher M Walker, Zongdi Feng
Nature Reviews. Microbiology. 2023-09-01 - 4 citationsViral protease cleavage of MAVS in genetically modified mice with hepatitis A virus infection.Lu Sun, Hui Feng, Ichiro Misumi, Takayoshi Shirasaki, Lucinda Hensley
Journal of Hepatology. 2023-02-01
Press Mentions
- Preclinical Study Demonstrates Effective Oral Treatment Against Hepatitis a VirusJuly 6th, 2022
- Key Player in Hepatitis A Infection ContaminationMay 31st, 2020
- Researchers Unearth Gatekeepers to Hepatitis A Virus Infection of Human CellsMay 28th, 2020
Grant Support
- Murine Model Of Hcv-Associated Human Liver CancerNational Cancer Institute2012
- Micro-Rna 122 And Chronic Hepatitis CNational Institute Of Allergy And Infectious Diseases2011–2012
- Hepatitis C And Tumor Suppressors In HepatocellularNational Cancer Institute2009–2011
- Intrahepatic IRF-3 And Nf-Kb Signaling And Interferon Responses In Hepatitis CNational Institute Of Allergy And Infectious Diseases2009–2010
- Administrative ServicesNational Institute Of Allergy And Infectious Diseases2006–2010
- Interferon Signaling And Cellular Permissiveness For Hepatitis C Virus (HCV)National Institute Of Allergy And Infectious Diseases2008–2009
- The Southeastern Cooperative Hepatitis C Research GroupNational Institute Of Allergy And Infectious Diseases2000–2009
- Hepatic Inflammation And Immunity 2008National Institute Of Allergy And Infectious Diseases2008
- Galveston National Laboratory OperationsNational Institute Of Allergy And Infectious Diseases2006–2008
- Interferon Signaling And Cellular Permissiveness For Hepatitis C VirusNational Institute Of Allergy And Infectious Diseases2007
- Southeastern Cooperative Hepatitis C Research GroupNational Center For Research Resources2003–2007
- Interferon Signaling And Cellular Permissiveness For HCVNational Institute Of Allergy And Infectious Diseases2005–2006
- Chimeric Virus Primate Model Of Hepatitis CNational Center For Research Resources2003–2006
- Administrative CoreNational Institute Of Allergy And Infectious Diseases2005
- Chimeric Virus Primate Model Of Hepatitis CNational Center For Research Resources2002–2005
- General Clinical Research CenterNational Center For Research Resources1999–2004
- National Biocontainment Laboratory (NBL)National Institute Of Allergy And Infectious Diseases2003
- Hepatic Inflammation And Immunity 2002National Institute Of Allergy And Infectious Diseases2002
- Selection Of Cell Culture-Adapted Hepatitis C RNANational Institute Of Allergy And Infectious Diseases1996–2002
- Extramural Research Facilities ConstructionNational Center For Research Resources2000
- Structure/Function Relations In HAV ReplicationNational Institute Of Allergy And Infectious Diseases1997–2000
- Rhinovirus Replicons As Vectors For Mucosal ImmunizationNational Institute Of Allergy And Infectious Diseases1997–2000
- Hepatic Inflammation And ImmunityNational Institute Of Allergy And Infectious Diseases1999
- Expansion And Renovation Of Utmb'S GcrcNational Center For Research Resources1999
- Southeastern Cooperative Hepatitis C Research GroupNational Institute Of Allergy And Infectious Diseases1997–1999
- Southeastern Cooperative Hepatitis C Research GroupNational Institute Of Allergy And Infectious Diseases1996
- Rhinovirus Replicons As Vectors For Mucosal ImmunizationNational Institute Of Allergy And Infectious Diseases1996
- Structure-Function Relations In HAV ReplicationNational Institute Of Allergy And Infectious Diseases1995–1996
- Infectious Disease Pathogenesis Research TrainingNational Institute Of Allergy And Infectious Diseases1993–1996
- Structure-Function Relations In HIV ReplicationNational Institute Of Allergy And Infectious Diseases1993–1994
- Immunogenic Epitopes Of HCV Envelope ProteinsNational Cancer Institute1992–1994
- Infectious Disease PathogenesisNational Institute Of Allergy And Infectious Diseases1988–1992
- University Of North Carolina AIDS Clinical Study GroupNational Institute Of Allergy And Infectious Diseases1987–1990
- Hepatitis Delta Infections In HemophiliacsNational Heart, Lung, And Blood Institute1986–1990
- Cloning &Sequencing Of Hepatitis A Virus CDNANational Institute Of Allergy And Infectious Diseases1986–1988